Cargando…
Supragranular Pyramidal Cells Exhibit Early Metabolic Alterations in the 3xTg-AD Mouse Model of Alzheimer’s Disease
The impairment of cerebral glucose utilization is an early and predictive biomarker of Alzheimer’s disease (AD) that is likely to contribute to memory and cognition disorders during the progression of the pathology. Yet, the cellular and molecular mechanisms underlying these metabolic alterations re...
Autores principales: | Piquet, Juliette, Toussay, Xavier, Hepp, Régine, Lerchundi, Rodrigo, Le Douce, Juliette, Faivre, Émilie, Guiot, Elvire, Bonvento, Gilles, Cauli, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060432/ https://www.ncbi.nlm.nih.gov/pubmed/30072874 http://dx.doi.org/10.3389/fncel.2018.00216 |
Ejemplares similares
-
Efficient gene delivery and selective transduction of astrocytes in the mammalian brain using viral vectors
por: Merienne, Nicolas, et al.
Publicado: (2013) -
Olfactory dysfunction in the 3xTg-AD model of Alzheimer’s disease
por: Mitrano, Darlene A., et al.
Publicado: (2021) -
Dopaminergic dysfunction in the 3xTg-AD mice model of Alzheimer’s disease
por: Gloria, Yesica, et al.
Publicado: (2021) -
Gender-Specific Neuroimmunoendocrine Response to Treadmill Exercise in 3xTg-AD Mice
por: Giménez-Llort, Lydia, et al.
Publicado: (2010) -
Impaired Spatial Reorientation in the 3xTg-AD Mouse Model of Alzheimer’s Disease
por: Stimmell, Alina C., et al.
Publicado: (2019)